XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Capitalization
 9 Months Ended
Jun. 30, 2024
Capitalization, Long-Term Debt and Equity [Abstract]  
Capitalization Capitalization
Summary of Changes in Common Stock Equity
 Common StockPaid In
Capital		Earnings
Reinvested
in the
Business		Accumulated
Other
Comprehensive
Income (Loss)
SharesAmount
 (Thousands, except per share amounts)
Balance at April 1, 202492,032 $92,032 $1,045,929 $2,090,172 $75,340 
Net Loss Available for Common Stock(54,158)
Dividends Declared on Common Stock ($0.515 Per Share)
(47,195)
Other Comprehensive Loss, Net of Tax(70,290)
Share-Based Payment Expense (1)
4,905 
Common Stock Issued Under Stock and Benefit Plans11 11 587 
Share Repurchases Under Repurchase Plan(431)(431)(4,942)(18,435)
Balance at June 30, 202491,612 $91,612 $1,046,479 $1,970,384 $5,050 
Balance at October 1, 202391,819 $91,819 $1,040,761 $1,885,856 $(55,060)
Net Income Available for Common Stock245,134 
Dividends Declared on Common Stock ($1.505 Per Share)
(138,354)
Other Comprehensive Income, Net of Tax60,110 
Share-Based Payment Expense (1)
14,262 
Common Stock Issued (Repurchased) Under Stock and Benefit Plans320 320 (2,514)
Share Repurchases Under Repurchase Plan(527)(527)(6,030)(22,252)
Balance at June 30, 202491,612 $91,612 $1,046,479 $1,970,384 $5,050 
Balance at April 1, 202391,795 $91,795 $1,031,341 $1,810,454 $(54,864)
Net Income Available for Common Stock92,620 
Dividends Declared on Common Stock ($0.495 Per Share)
(45,444)
Other Comprehensive Income, Net of Tax5,480 
Share-Based Payment Expense (1)
4,009 
Common Stock Issued Under Stock and Benefit Plans9 9 502 
Balance at June 30, 202391,804 $91,804 $1,035,852 $1,857,630 $(49,384)
Balance at October 1, 202291,478 $91,478 $1,027,066 $1,587,085 $(625,733)
Net Income Available for Common Stock403,189 
Dividends Declared on Common Stock ($1.445 Per Share)
(132,644)
Other Comprehensive Income, Net of Tax576,349 
Share-Based Payment Expense (1)
14,327 
Common Stock Issued (Repurchased) Under Stock and Benefit Plans
326 326 (5,541)
Balance at June 30, 202391,804 $91,804 $1,035,852 $1,857,630 $(49,384)

(1)Paid in Capital includes compensation costs associated with performance shares and/or restricted stock awards. The expense is included within Net Income Available For Common Stock, net of tax benefits.

Common Stock.  During the nine months ended June 30, 2024, the Company issued 112,667 original issue shares of common stock for restricted stock units that vested and 251,255 original issue shares of common stock for performance shares that vested.  The Company also issued 27,310 original issue shares of common stock to the non-employee directors of the Company who receive compensation under the Company’s 2009 Non-Employee Director Equity Compensation Plan, including the reinvestment of dividends for certain non-employee directors who elected to defer their shares pursuant to the dividend reinvestment feature of the Company's Deferred Compensation Plan for Directors and Officers (the "DCP") during the nine months ended June 30, 2024.  In addition, the Company issued 5,964 original issue shares of common stock to officers of the
Company who elected to defer their shares pursuant to the dividend reinvestment feature of the Company's DCP Plan during the nine months ended June 30, 2024. Holders of stock-based compensation awards will often tender shares of common stock to the Company for payment of applicable withholding taxes.  During the nine months ended June 30, 2024, 77,461 shares of common stock were tendered to the Company for such purposes.  The Company considers all shares tendered as cancelled shares restored to the status of authorized but unissued shares, in accordance with New Jersey law.

    On March 8, 2024, the Company’s Board of Directors authorized the Company to implement a share repurchase program, whereby the Company may repurchase outstanding shares of common stock, up to an aggregate amount of $200 million in the open market or through privately negotiated transactions, including through the use of trading plans intended to qualify under SEC Rule 10b5-1, in accordance with applicable securities laws and other restrictions. During the nine months ended June 30, 2024, the Company executed transactions to repurchase 526,652 shares at an average price of $54.28 per share. With broker fees and excise taxes, the total cost of these repurchases amounted to $28.8 million. Share repurchases that settled during the nine months ended June 30, 2024 were funded with cash provided by operating activities and/or short-term borrowings. In the future, it is expected that this share repurchase program will continue to be funded with cash provided by operating activities and/or through the use of short-term borrowings.

Short-Term Borrowings. On February 28, 2022, the Company entered into a Credit Agreement (as amended from time to time, the "Credit Agreement") with a syndicate of twelve banks. The Credit Agreement replaced the previous Fourth Amended and Restated Credit Agreement and a previous 364-Day Credit Agreement. As initially entered, the Credit Agreement provided a $1.0 billion unsecured committed revolving credit facility with a maturity date of February 26, 2027. In February 2024, the Company and eleven of the banks in the syndicate consented to an extension of the maturity date of the Credit Agreement from February 26, 2027 to February 25, 2028. In May 2024, three of the banks in the syndicate assumed the commitments of the sole non-extending lender such that the Company has aggregate commitments available under the Credit Agreement in the full amount of $1.0 billion to February 25, 2028.
 
Current Portion of Long-Term Debt. The Current Portion of Long-Term Debt at June 30, 2024 consisted of $50.0 million of 7.375% notes that mature in June 2025. None of the Company's long-term debt as of September 30, 2023 had a maturity date within the following twelve-month period.

Delayed Draw Term Loan. On February 14, 2024, the Company entered into a Term Loan Agreement (the “Term Loan Agreement”) with six lenders, all of which are lenders under the Credit Agreement. The Term Loan Agreement provides a $300.0 million unsecured committed delayed draw term loan facility with a maturity date of February 14, 2026, and the Company has the ability to select interest periods of one, three or six months for borrowings. In April 2024, pursuant to the delayed draw mechanism, the Company elected to draw a total of $300.0 million under the facility. The Company selected an initial six month interest period for these borrowings, locking in a weighted average interest rate of 6.705% through the beginning of October 2024. After deducting debt issuance costs, the net proceeds to the Company amounted to $299.4 million. The Company used the proceeds for general corporate purposes, which included the redemption of outstanding commercial paper.